Panagora Asset Management’s AnaptysBio ANAB Stock Holding History

Panagora Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,872	Closed	-$1.01M	–	1164
2025 Q4	$1.01M	Sell	20,872 -42,985	-67%	-$1.68M	﹤0.01%	716
2025 Q3	$1.96M	Buy	63,857 +30,488	+91%	+$700K	0.01%	528
2025 Q2	$741K	Buy	+33,369	New	+$698K	﹤0.01%	701
2022 Q2	–	Sell	-26,479	Closed	-$655K	–	1463
2022 Q1	$655K	Buy	26,479 +59	+0.2%	+$1.79K	﹤0.01%	1116
2021 Q4	$918K	Buy	26,420 +342	+1%	+$10.8K	﹤0.01%	963
2021 Q3	$707K	Buy	26,078 +25,819	+9,969%	+$655K	﹤0.01%	1141
2021 Q2	$7K	Sell	259 -1,581	-86%	-$37.9K	﹤0.01%	2360
2021 Q1	$40K	Hold	1,840	–	–	﹤0.01%	2221
2020 Q4	$39K	Hold	1,840	–	–	﹤0.01%	2089
2020 Q3	$27K	Sell	1,840 -30,116	-94%	-$543K	﹤0.01%	2136
2020 Q2	$714K	Sell	31,956 -87,489	-73%	-$1.6M	﹤0.01%	1059
2020 Q1	$1.69M	Buy	119,445 +35,073	+42%	+$532K	0.01%	648
2019 Q4	$1.37M	Buy	+84,372	New	+$2M	0.01%	933

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Panagora Asset Management's ANAB Position: Q1 2026 in Review

Panagora Asset Management sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 20,872 shares — an estimated $1.01M sold.

Panagora Asset Management first reported a position in ANAB in Q4 2019 and held it in 13 quarters. The position peaked at $1.96M in Q3 2025. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Panagora Asset Management reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
Panagora Asset Management sold 20,872 AnaptysBio shares in Q1 2026, an estimated $1.01M.
Panagora Asset Management first reported a position in AnaptysBio in Q4 2019 and held it in 13 quarters.
Panagora Asset Management's AnaptysBio position peaked at $1.96M in Q3 2025.
208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.